Literature DB >> 1401009

Antigenic and molecular characterization of bat rabies virus in Europe.

H Bourhy1, B Kissi, M Lafon, D Sacramento, N Tordo.   

Abstract

The predominant role of Eptesicus serotinus in the epizootic of bat rabies in Europe was further outlined by the first isolation of the rabies virus from this species in France. The distribution of the virus was studied in naturally infected E. serotinus bats at the time of death and suggested that the papillae of the tongue and the respiratory mucosa may play a role in virus production and excretion. The analysis of 501 French rabies virus isolates from various animal species by antinucleocapsid monoclonal antibodies indicated that transmission of the disease from bats to terrestrial animals is unlikely. The antigenic profile of two isolates from French bats corresponded to that of European bat lyssavirus type 1 (EBL1). Comparisons of 12 different isolates from bats with antinucleocapsid and antiglycoprotein monoclonal antibodies and by direct sequencing of the polymerase chain reaction amplification product of the N gene indicated that EBL1, EBL2, Duvenhage virus (serotype 4 of lyssavirus), and the European fox rabies virus (serotype 1) are phylogenetically distant. They formed four tight genetic clusters named genotypes. EBL1 was shown to be antigenically and genetically more closely related to Duvenhage virus than to EBL2. We propose that EBL1 and EBL2 constitute two distinct genotypes which further serologic characterization will probably classify as new serotypes. We also report a simple method for the rapid characterization of EBL based on the digestion of the polymerase chain reaction product of the N gene by three restriction endonucleases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401009      PMCID: PMC265516          DOI: 10.1128/jcm.30.9.2419-2426.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Molecular epidemiology of rabies virus in France: comparison with vaccine strains.

Authors:  D Sacramento; H Badrane; H Bourhy; N Tordo
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

2.  PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus.

Authors:  D Sacramento; H Bourhy; N Tordo
Journal:  Mol Cell Probes       Date:  1991-06       Impact factor: 2.365

3.  Propagation of Rabies Virus in Pig Kidney Cell Culture.

Authors:  M K Abelseth
Journal:  Can Vet J       Date:  1964-04       Impact factor: 1.008

4.  Antigenic sites on the ERA rabies virus nucleoprotein and non-structural protein.

Authors:  M Lafon; T J Wiktor
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

5.  The rabies viruses of bats.

Authors:  A King; P Davies; A Lawrie
Journal:  Vet Microbiol       Date:  1990-06       Impact factor: 3.293

6.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

7.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

8.  Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.

Authors:  K K Conzelmann; J H Cox; L G Schneider; H J Thiel
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

9.  A reduced panel of anti-nucleocapsid monoclonal antibodies for bat rabies virus identification in Europe.

Authors:  J A Hirose; H Bourhy; M Lafon
Journal:  Res Virol       Date:  1990 Sep-Oct

10.  Unexplained rabies in three immigrants in the United States. A virologic investigation.

Authors:  J S Smith; D B Fishbein; C E Rupprecht; K Clark
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

View more
  35 in total

1.  Development of a real-time, TaqMan reverse transcription-PCR assay for detection and differentiation of lyssavirus genotypes 1, 5, and 6.

Authors:  P R Wakeley; N Johnson; L M McElhinney; D Marston; J Sawyer; A R Fooks
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  A molecular epidemiological study of rabies in Cuba.

Authors:  S A Nadin-Davis; G Torres; M De Los Angeles Ribas; M Guzman; R Cruz De La Paz; M Morales; A I Wandeler
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

3.  A Dynein Light Chain 1 Binding Motif in Rabies Virus Polymerase L Protein Plays a Role in Microtubule Reorganization and Viral Primary Transcription.

Authors:  Anja Bauer; Tobias Nolden; Sabine Nemitz; Eran Perlson; Stefan Finke
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

4.  Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses.

Authors:  P R Heaton; P Johnstone; L M McElhinney; R Cowley; E O'Sullivan; J E Whitby
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 5.  Human Rabies: a 2016 Update.

Authors:  Alan C Jackson
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

6.  Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.

Authors:  H Badrane; C Bahloul; P Perrin; N Tordo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Serologic evidence of Lyssavirus infections among bats, the Philippines.

Authors:  Paul M Arguin; Kristy Murray-Lillibridge; Mary E G Miranda; Jean S Smith; Alan B Calaor; Charles E Rupprecht
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  Encephalitis caused by a Lyssavirus in fruit bats in Australia.

Authors:  G C Fraser; P T Hooper; R A Lunt; A R Gould; L J Gleeson; A D Hyatt; G M Russell; J A Kattenbelt
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

9.  European bat lyssavirus infection in Spanish bat populations.

Authors:  Jordi Serra-Cobo; Blanca Amengual; Carlos Abellán; Hervé Bourhy
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

10.  Chimeric lyssavirus glycoproteins with increased immunological potential.

Authors:  C Jallet; Y Jacob; C Bahloul; A Drings; E Desmezieres; N Tordo; P Perrin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.